BAX and in situ carcinoma: The effects of SH in a dose of 100 mg/kg/d on cisplatin-induced alterations of Bax and Bcl-2, as well as their ratio (p < 0.01), compared to the CIS group were very similar to the effects of simultaneous administration of silymarin in an equal dose.